Programmable transdermal drug delivery

Information

  • Research Project
  • 7804706
  • ApplicationId
    7804706
  • Core Project Number
    R44AR055837
  • Full Project Number
    2R44AR055837-02
  • Serial Number
    55837
  • FOA Number
    PA-09-080
  • Sub Project Id
  • Project Start Date
    4/1/2008 - 16 years ago
  • Project End Date
    7/31/2012 - 12 years ago
  • Program Officer Name
    CIBOTTI, RICARDO
  • Budget Start Date
    8/1/2010 - 14 years ago
  • Budget End Date
    7/31/2011 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    2
  • Suffix
  • Award Notice Date
    8/1/2010 - 14 years ago
Organizations

Programmable transdermal drug delivery

DESCRIPTION (provided by applicant): Prostate cancer and central precocious puberty - linked through improper gonadal steroid levels - are most common in either the elderly or youth populations. Similar gonadal steroid problems also connected to endometriosis. Some traditional methodologies for treating these illnesses involves daily injections of medicine, which can become painful or be forgotten, result in under-dosing. Los Gatos Research is developing an alternative method for delivering time-controlled drug formulations that is practically pain free. Furthermore, the novel technology provides an extended, programmable release platform that helps patients avoid the need to remember to take medication (particularly important for portions of the elderly population) and offers the potential to use less medicine to produce the same effect due to the ability to customize the delivery to the individual patient. The technologies developed in this proposed project enable programmable, microfluidic transdermal patches to provide a means for delivering large molecular weight drug formulations that is controlled, painless, and direct. The specific aims of the Phase II project include upgrading the unique programmable transdermal patches, testing and validating their performance capabilities, optimizing them for rapid, controlled delivery of medication to control gonadal steroid levels, and conducting initial pre- clinical trials of the patches.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R44
  • Administering IC
    AR
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    374384
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
    NIAMS:374384\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LOS GATOS RESEARCH
  • Organization Department
  • Organization DUNS
    928805761
  • Organization City
    MOUNTAIN VIEW
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    940411529
  • Organization District
    UNITED STATES